This small bit caught my eye in case study one on page 1 of the PDF-:• At two years, resorption of the biomaterial is almost complete, and patient is pain-free.
That was back on the 18/7/2013 when this PDF was written.
As can be seen in my previous post, we supplied S&N with BTM back in 2012, I know US Government agencies seem to take forever to reach a conclusion, just look at BARDA? DARPA would be no exception, this STRUCSURE CP Macroporous Calcium Phosphate Bone Graft Substitute, may be no different, it may be that DARPA has held up sales in this area until it is approved by DARPA and then FDA approval? hope I am right about this?
strucsure_case study.pdf
PNV Price at posting:
59.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)